Park, J., Sahm, F., Steffl, B., Arrillaga-Romany, I., Cahill, D., Monje, M., . . . Turcan, S. (2021). TERT and DNMT1 expression predict sensitivity to decitabine in gliomas. Neuro-Oncology, 23(1), . https://doi.org/10.1093/neuonc/noaa207
Chicago Style (17th ed.) CitationPark, Jongwhi, Felix Sahm, Bianca Steffl, Isabel Arrillaga-Romany, Daniel Cahill, Michelle Monje, Christel Herold-Mende, Wolfgang Wick, and Sˍevin Turcan. "TERT and DNMT1 Expression Predict Sensitivity to Decitabine in Gliomas." Neuro-Oncology 23, no. 1 (2021). https://doi.org/10.1093/neuonc/noaa207.
MLA (9th ed.) CitationPark, Jongwhi, et al. "TERT and DNMT1 Expression Predict Sensitivity to Decitabine in Gliomas." Neuro-Oncology, vol. 23, no. 1, 2021, https://doi.org/10.1093/neuonc/noaa207.
Warning: These citations may not always be 100% accurate.